WARDWIZARD HEALTHCARE LIMITED
Fundamental Score
WARDWIZARD HEALTHCARE LIMITED Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of WARDHEALTH across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (62.32%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Consistent Growth Track Record (69.52% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Balanced Promoter Holding (74.08%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Suboptimal ROCE (-58.66%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-202.80%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Weak Interest Coverage (-4.48x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-2.07 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for WARDWIZARD HEALTHCARE LIMITED
About WARDHEALTH
Business Overview
Wardwizard Healthcare Limited engages in the business of hospital activities. The company also offers healthcare services and activities related to Ayurveda practitioners. The company was formerly known as Ayoki Merchantile Limited and changed its name to Wardwizard Healthcare Limited in August 2023. Wardwizard Healthcare Limited was incorporated in 1985 and is based in Vadodara, India.
Company Details
Key Leadership
WARDHEALTH Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of WARDWIZARD HEALTHCARE LIMITED (WARDHEALTH)?
As of 02 Jan 2026, 02:30 pm IST, WARDWIZARD HEALTHCARE LIMITED (WARDHEALTH) is currently trading at ₹45.34. The stock has a market capitalization of ₹1.01 (Cr).
Is WARDHEALTH share price Overvalued or Undervalued?
WARDHEALTH is currently trading at a P/E ratio of 0.00x, compared to the industry average of 35.45x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the WARDWIZARD HEALTHCARE LIMITED share price?
Key factors influencing WARDHEALTH's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is WARDWIZARD HEALTHCARE LIMITED a good stock for long-term investment?
WARDWIZARD HEALTHCARE LIMITED shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing.
How does WARDWIZARD HEALTHCARE LIMITED compare with its industry peers?
WARDWIZARD HEALTHCARE LIMITED competes with major peers in the Trading & Distributors. Investors should compare WARDHEALTH's P/E of 0.00x and ROE of N/A% against the industry averages to determine its competitive standing.
What is the P/E ratio of WARDHEALTH and what does it mean?
WARDHEALTH has a P/E ratio of N/Ax compared to the industry average of 35.45x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is WARDHEALTH performing according to Bull Run's analysis?
WARDHEALTH has a Bull Run fundamental score of 28/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does WARDHEALTH belong to?
WARDHEALTH operates in the Trading & Distributors industry. This classification helps understand the competitive landscape and sector-specific trends affecting WARDWIZARD HEALTHCARE LIMITED.
What is Return on Equity (ROE) and why is it important for WARDHEALTH?
WARDHEALTH has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently WARDWIZARD HEALTHCARE LIMITED generates profits from shareholders' equity.
How is WARDHEALTH's debt-to-equity ratio and what does it indicate?
WARDHEALTH has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is WARDHEALTH's dividend yield and is it a good dividend stock?
WARDHEALTH offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has WARDHEALTH grown over the past 5 years?
WARDHEALTH has achieved 5-year growth rates of: Sales Growth 69.52%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in WARDHEALTH and why does it matter?
Promoters hold 74.08% of WARDHEALTH shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is WARDHEALTH's market capitalization category?
WARDHEALTH has a market capitalization of ₹1 crores, placing it in the Small-cap category.
How volatile is WARDHEALTH stock?
WARDHEALTH has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for WARDHEALTH?
WARDHEALTH has a 52-week high of ₹N/A and low of ₹N/A.
What is WARDHEALTH's operating profit margin trend?
WARDHEALTH has a 5-year average Operating Profit Margin (OPM) of -202.80%, indicating the company's operational efficiency.
How is WARDHEALTH's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of 62.32%.
What is the institutional holding pattern in WARDHEALTH?
WARDHEALTH has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.